Hong Zhao - Concepedia

Author

Hong Zhao

Chinese Academy of Medical Sciences & Peking Union Medical College ORCID

Also Known As

H Zhao, H. Zhao, HONG ZHAO, Haile Zhao, Hong Guang Zhao, Hong Zhao, Zhao H, Zhao, H., Zhao, Hong

127

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College Sun Yat-sen University Peking University Sun Yat-sen University Cancer Center National Cancer Center

About

Hong Zhao is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	1.9K
2	Health Sciences	3	3	637
3	Public Health	2	2	28
4	Engineering	1	1	11
5	Natural Sciences	1	1	421

Hong Zhao

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma Meng Li, Hong Zhao, Laura D. Wood, Nature Genetics ChromatinTumor BiologyChromatin StructureGene Arid2Chromatin Remodeling	2011	421
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, The Lancet Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma	2023	415
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial Josep M. Llovet, Masatoshi Kudo, Philippe Merle, The Lancet Oncology OncologyHepatologyMedicineClinical TrialsPembrolizumab Versus Lenvatinib	2023	364
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy Chunfeng Qu, Yuting Wang, Pei Wang, Proceedings of the National Academy of Sciences Asymptomatic Hbsag-seropositive IndividualsPathologyHepatic DisordersViral HepatitisBioanalysis	2019	174
Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma Weilong Zhang, Huan He, Mengya Zang, Gastroenterology	2017	171
A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway Hong Zhao, Yuming Guo, Shu Li, Oncotarget	2015	150
Oncogenic Kinase–Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem–like Cells Zhifen Zhou, Min Li, Lin Zhang, Cancer Research	2018	101
Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species Jin Zhou, Pu Li, Xiaofeng Xue, Toxicology Letters Chemoprevention StrategyCell DeathReactive Oxygen SpeciesCancer BiologyTumor Biology	2013	99
Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center Minjie Wang, Yuting Wang, Xiaoshuang Feng, International Journal of Infectious Diseases Hepatitis DHepatologyHepatitis CHepatitis C VirusViral Hepatitis	2017	93
RIPK1 Binds MCU to Mediate Induction of Mitochondrial Ca2+ Uptake and Promotes Colorectal Oncogenesis Fanxin Zeng, Xiao Chen, Weiyi Cui, Cancer Research	2018	89

Page 1